At a glance
ClinicalIndex Comparison RecordN/ACompleted· 509 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
In Brief
An observational study for Multiple Sclerosis. Completed, enrolled 509 participants across 1 site.
Detailed Summary
The overall objective of this study is to collect data relevant to the tolerability of Novantrone® therapy in patients with multiple sclerosis (MS) using dosing and monitoring recommendations specified in the package insert.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2000
First PostedDec 2005
Primary CompletionJan 2008
Study CompletionSep 2008
TodayJul 2026
First PostedDec 6, 2005
Enrollment StartOct 1, 2000
Primary CompletionJan 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 20.6 years ago